Home/Filings/4/0001618835-20-000218
4//SEC Filing

PELLETIER SAUNDRA L 4

Accession 0001618835-20-000218

CIK 0001618835other

Filed

Sep 9, 8:00 PM ET

Accepted

Sep 10, 8:04 PM ET

Size

5.5 KB

Accession

0001618835-20-000218

Insider Transaction Report

Form 4
Period: 2020-09-08
PELLETIER SAUNDRA L
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2020-09-08$3.26/sh122,500$399,350360,888 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.09 to $3.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]The total amount of securities beneficially owned includes 4,303 shares of common stock the reporting person purchased in accordance with the 2019 ESPP based on 85% of the closing stock price on June 12,2020, the last trading day of the purchase period.

Issuer

Evofem Biosciences, Inc.

CIK 0001618835

Entity typeother

Related Parties

1
  • filerCIK 0001251371

Filing Metadata

Form type
4
Filed
Sep 9, 8:00 PM ET
Accepted
Sep 10, 8:04 PM ET
Size
5.5 KB